PDGF receptors as cancer drug targets
Top Cited Papers
Open Access
- 1 May 2003
- journal article
- review article
- Published by Elsevier in Cancer Cell
- Vol. 3 (5) , 439-443
- https://doi.org/10.1016/s1535-6108(03)00089-8
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- A Tyrosine Kinase Created by Fusion of thePDGFRAandFIP1L1Genes as a Therapeutic Target of Imatinib in Idiopathic Hypereosinophilic SyndromeNew England Journal of Medicine, 2003
- A human brain tumor-derived PDGFR-α deletion mutant is transformingOncogene, 2003
- Phase I Safety, Pharmacokinetic, and Pharmacodynamic Trial of ZD1839, a Selective Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Five Selected Solid Tumor TypesJournal of Clinical Oncology, 2002
- Angiogenesis stimulated by PDGF‐CC, a novel member in the PDGF family, involves activation of PDGFR‐aa and ‐ap receptorsThe FASEB Journal, 2002
- Response to Imatinib Mesylate in Patients with Chronic Myeloproliferative Diseases with Rearrangements of the Platelet-Derived Growth Factor Receptor BetaNew England Journal of Medicine, 2002
- Glivec (STI571, imatinib), a rationally developed, targeted anticancer drugNature Reviews Drug Discovery, 2002
- Pharmacodynamic Studies of the Epidermal Growth Factor Receptor Inhibitor ZD1839 in Skin From Cancer Patients: Histopathologic and Molecular Consequences of Receptor InhibitionJournal of Clinical Oncology, 2002
- PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivoGenes & Development, 2001
- Developmental roles of platelet‐derived growth factorsBioEssays, 2001
- MMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin CarcinogenesisCell, 2000